As the only FDA approved equine PSGAG (polysulfated glycosaminoglycan) for degenerative joint disease (DJD) in horses, Adequan®
i.m actually treats degenerative joint disease (DJD), not just its clinical signs. For over 30 years, Adequan® i.m has been
administered by veterinarians to help horses of every discipline and level enjoy greater mobility over their lifetimes. FDA
Approved.